发明名称 SINGLE NUCLEOTIDE POLYMORPHISMS SENSITIVELY PREDICTING ADVERSE DRUG REACTIONS (ADR) AND DRUG EFFICACY
摘要 The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The invention provides further diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Still further the invention provides polymorphic sequences and other genes. <??>The present invention further relates to isolated polynucleotides encoding a phenotype associated (PA) gene polypeptide useful in methods to identify therapeutic agents and useful for preparation of a medicament to treat cardiovascular disease or influence drug response, the polynucleotide is selected from the group comprising: SEQ ID 1-168 with allelic variation as indicated in the sequences section contained in a functional surrounding like full length cDNA for PA gene polypeptide and with or without the PA gene promoter sequence.
申请公布号 EP1532277(A2) 申请公布日期 2005.05.25
申请号 EP20030792358 申请日期 2003.08.18
申请人 SIEMENS HEALTHCARE DIAGNOSTICS GMBH 发明人 SCHWERS, STEPHAN;KALLABIS, HARALD;STROPP, UDO
分类号 A61K48/00;C07K14/47;C12N15/63;C12Q1/68;G01N33/50;G01N33/68;(IPC1-7):C12Q1/68 主分类号 A61K48/00
代理机构 代理人
主权项
地址